July 03, 2017
Wellesley, Mass., Jul 03, 2017 – Global demand for allergy diagnosis and treatment is poised for nearly 6% CAGR in the next five years, according to new BCC Research report. Existing drugs are losing patent protections, new therapies are growing and, geographically, the Asia market is expanding rapidly, the study found. Generic options and acquisitions are having a business impact, detailed in Global Markets for Allergy Diagnostics and Treatments and immunotherapy may shift treatment options globally.
This BCC research report is the latest examination of the world’s largest pharmaceutical and diagnostics companies in a $39.5 billion market, according to 2016 sales. Merck, GlaxoSmithKine, Pfizer, Bayer Healthcare, Procter&Gamble and Sanofi are just some of the producers seeing a single-digit percentage increase in prescriptions. More than half of the diagnostic market is spending from the U.S. But testing/diagnostic in Asia is seeing a 16 % CAGR – the smallest global market, but the fastest growing, for companies such as Alere, BeckmanCoulter, Quest Diagnostics and market-leader ThermoFisher.
"Foods, seasonal pollen, mold and other allergies pose a range of impacts – from minor irritation and runny noses to life-threatening anaphylactic shock. In the U.S. alone, the Centers for Disease Control says there are more than 50 million affected people,” says Robert Hunter, senior healthcare editor atBCC Research. "This is a very dynamic medical and economic marketplace with multinational players that have a significant role in everyday life for patients.”
Editors and reporters who wish to speak with the analyst should contact Steven Cumming at firstname.lastname@example.org.
Global Markets for Allergy Diagnostics and Treatments( PHM026C )
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email email@example.com or visit www.bccresearch.com/media to request access to our library of market research.